维普中文期刊产品整合服务
35篇 您的检索式:作者名="Brigida D"
    题名 作者 年代 出处 被引量
1Potential allelopathic effects of stilbenoids and flavonoids from leaves of Carex distachya Desf 显示文摘Antonio F Brigida D Severina P 2008Biochem Syst Ecol2008,36,9:1
2‘ Limoncella' apple, an Italian apple cultivar: Phenolic and flavonoid con- tents and antioxidant activity显示文摘D' Abrosca Brigida Pacifico Severina Cefarelli Giuseppe 2007Food Chemistry2007,104,4:1
3Gut microbiota and metabolic syndrome显示文摘Francesca D’Aversa Annalisa Tortora Gianluca Ianiro Francesca Romana Ponziani Brigida Eleonora Annicchiarico Antonio Gasbarrini 2013Internal and Emergency Medicine2013,,1:1
4Second generation ultrasonographic contrast agents in the diagnosis of neoplastic thyroid nodules显示文摘APPETECCHIA M BACARO D BRIGIDA R 2006J Exp Clin Cancer Res2006,25,11:1
5Second generation ultrasonographic contrast agents in the diagnosis of neoplastic thyroid nodules 显示文摘APPETECCHIA M BACARO D BRIGIDA R 2006J Exp Ciin Caneer Res2006,25,3:1
6Lignans and neolignans from Brassica fruticulosa:effects on seed germination and plant growth显示文摘Francesca C Brigida D Marina D 0,,:1
7Second generation ultrasonographic contrast agents in the diagnosis of neoplastic thyroidnodules显示文摘Appetecchia M Bacro D Brigida R 0,,03:1
8Second generation ultrasonographic contrast agents in the diagnosis of neoplastic thyroid nodules显示文摘Appetecchia M Bacaro D Brigida R 2006J Exp Clin Cancer Res2006,25,3:1
9Second generation ul- trasonographic contrast agents in the diagnosis of neoplastic thy- roid nodules显示文摘Appetecchia M Bacaro D Brigida R 2006J Exp Clin Cancer Res2006,25,3:1
10Second generation ultrasonographic contrast agents in the diagnosis of neoplastic thyroid nodules显示文摘Appetecchia M Bacro D Brigida R 2006J Exp Clin Cancer Res2006,25,3:1
11Characterization of volatile constituents in commercial oak wood chips显示文摘BRIGIDA F D S IRIA M ESTRELLA C 2010Journal of Agricultural and Food Chemistry2010,58,17:1
12Second generation ultrasonographic contrast agents in the diagnosis of neoplastic thyroid nodules显示文摘Appetecchia M Bacaro D Brigida R 2006J Exp Clin Cancer Res2006,25,3:1
13Potential allelopathic effects of stilbenoids and flavonoids from leaves of Carex distachya Desf显示文摘Antonio F Brigida D Severina P 2008Bioche Syst Ecol2008,36,9:1
14替度鲁肽用于正接受肠内营养支持的克罗恩病合并短肠综合征患者的疗效:跳出传统思维显示文摘Introduction Short bowel syndrome(SBS)is a disorder characterized by malabsorption due to the absence or resection of a long small intestine tract,with an incidence of 2 per million of habitants.In adults,SBS is defined as less than 200 cm without colon and less than 50 cm with residual colon in continuity[1].The causes of SBS in adult patients are different,but the most frequent one(33.3%of the cases)is the need for surgery in patients with Crohn’s disease(CD)[2].Brigida Barberio Giacomo Carlo Sturniolo Renata D’Incà Fabio Farinati Maria Assunta Bigotto Matteo Ghisa Greta Lorenzon Edoardo Savarino 2019Gastroenterology Report2019,7,6:1
15Seeond generation ultrasonographic contrast agents in the diagnosis of neoplastic thyroid nodules 显示文摘Appetecchia M Bacro D Brigida R 2006J Exp Clin Cancer Res2006,25,3:1
16Identification and assessment of antioxidant capacity of phytochemicals from kiwi fruits 显示文摘Fiorentino Antonio D Abrosca Brigida Pacifico Severina 2009Journal of Agricultural and Food Chemistry2009,57,10:1
17Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation显示文摘AIM: To investigate differences in tolerability and response to treatment in compensated cirrhotic patients affected by hepatitis C virus (HCV) infection before and after liver transplantation. METHODS: Forty-three HCV non-liver transplanted (LT) cirrhotics (mean age 55 ± 8 years, 65.1% male, Child-Pugh-A, genotype 1-4: 65.1%, 2-3: 34.9%) and 17 LT recipients with recurrent HCV-related cirrhosis (mean age 57 ± 9 years, 88.2% male, Child-Pugh-A, genotype 1-4: 76.5%, 2-3: 23.5%) were included in the analysis from retrospective series. All patients received recombinant or pegylated interferon plus ribavirin at a standard dose and duration. Adverse events were recorded and classified according to the Common Terminology Criteria for Adverse Events. The mean duration of follow-up was of 4.3 ± 1.8 years after the end of the treatment. RESULTS: An early virological response (EVR) was achieved in 30/43 (69.8%) non-LT and in 8/17 (47.1%) LT cirrhotics, a sustained virological response (SVR) in 18/43 (41.9%) and 5/17 (29.4 %), respectively. No sta- tistical difference was observed in EVR and SVR rates between the two groups. Among HCV non-LT cirrhotics, 6/43 (13.9%) discontinued the treatment prematurely, 11.6% of them receiving ≤ 80% of treatment; 8/17 (47%) LT cirrhotics withdrew the treatment, 35.2% of them receiving ≤ 80% of treatment. If compared with LT-ones (P = 0.015), an higher risk of treatment discontinuation could affect LT cirrhotics, who undergo more frequently ≤ 80% of treatment (P = 0.05). None of the non-LT cirrhotics died after the end of the treatment. With no regards to the achievement of SVR, LT cirrhotic patients showed a reduced survival in respect to non-LT ones (87% at 1 year, 76% at 3 and 5 years after the end of treatment).CONCLUSION: HCV antiviral treatment is equally effective in compensated cirrhotics both before and after LT, which patients show a higher risk of premature treatment withdrawal and a reduced survival, independently of the achievement of SVR.Francesca Romana Ponziani Eleonora Brigida Annicchiarico Massimo Siciliano Francesca D'Aversa Maurizio Pompili Antonio Gasbarrini 2013World Journal of Gastroenterology2013,19,21:1
18Two new acylated drimane-type sesquiterpene glucosides from Petrorhagia saxifraga 显示文摘MONICA S BRIGIDA D VALERIA S 2014Phytochem Lett2014,7,2:1
19Cinnamie acid amides from Chenopodium album: effects on seeds germination and plant growth 显示文摘Francesca C Brigida D A Marina D G 2003Phytochemistry2003,64,:1
20Second generation ul- trasonographic eontrast agents in the dignosis of neoplastic thy roid nodules显示文摘Appeteeehia M Bacaro D Brigida R 2006Exp Clin Caneer Res2006,25,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费